BillionToOne and Epic Collaborate to Integrate Prenatal and Oncology Testing into EHR Workflows
The integration of BillionToOne’s UNITY Complete® and Northstar® tests into Epic aims to streamline ordering and result delivery, enhancing clinical workflows for prenatal and oncology diagnostics.
BillionToOne is integrating its prenatal and oncology molecular tests directly into Epic’s EHR to streamline clinical workflows, signaling a strategic shift toward embedding diagnostics in healthcare IT platforms; actual market impact depends on Epic client adoption and reimbursement validation.
The integration of BillionToOne’s UNITY Complete® and Northstar® tests into Epic aims to streamline ordering and result delivery, enhancing clinical workflows for prenatal and oncology diagnostics.
Valye News Insights
BillionToOne announced a collaboration with Epic to embed its molecular diagnostic tests, specifically UNITY Complete® for prenatal screening and Northstar® for oncology, within the Epic electronic health record (EHR) system. This enables clinicians to order tests and receive results seamlessly inside Epic’s software. This move directly targets improving provider and patient experiences by integrating testing into widely used clinical workflows.
From a Valye AI perspective, this partnership moves BillionToOne from standalone testing solutions toward ecosystem compatibility by addressing integration certainty with Epic’s dominant EHR platform. However, integration ≠ adoption; providers must still see operational and clinical value to shift behaviors, which typically requires demonstration of workflow efficiency and reimbursement clarity.
The industry is increasingly favoring solutions embedded in EHRs to reduce errors, accelerate decision-making, and improve patient management. One plausible scenario is that BillionToOne’s tests gain traction primarily at Epic’s large healthcare systems if they prove easy to order and report. Implementation will depend on Epic’s deployment schedules, client uptake, and regulatory or payer confirmations around test utility.
For investors, the materiality gate includes visible milestones such as active usage at pilot sites, Epic marketplace listing dates, and feedback on clinical throughput improvements. Revenue impact will hinge on scale achieved beyond proof-of-concept integrations and payer coverage, making the path to broader healthcare adoption the critical factor. In practical terms, that usually means milestones like Roadmap Proof Points and What Changes Minds.
Key numbers
- January 15, 2026 - announcement date of the collaboration
- UNITY Complete® and Northstar® - two specific diagnostic tests integrated
- Not disclosed - timeline for Epic integration rollout or client adoption
What changed
- Initiation of collaboration with Epic to integrate BillionToOne tests into Epic EHR
- Commitment to enable ordering and results delivery of UNITY Complete® and Northstar® within Epic
Bottom line: The collaboration formalizes integration with a leading EHR, but financial impact depends on healthcare provider adoption and payer reimbursement progress.
Key points
- BillionToOne partnered with Epic to integrate prenatal and oncology tests into Epic’s EHR.
- Integration allows seamless ordering and results delivery within Epic, improving provider workflows.
- Focus on UNITY Complete® (prenatal) and Northstar® (oncology) diagnostic tests.
- No disclosed timelines for Epic deployment or adoption rates.
- Material financial impact depends on Epic client uptake and reimbursement coverage.
Industry Analysis
- Embedding molecular diagnostics into EHRs reflects a broader trend toward clinical workflow integration.
- Epic is a leading healthcare IT platform widely used by large hospital networks.
- Integration reduces friction in test ordering and result interpretation, potentially improving uptake.
- Successful integration can create competitive barriers for standalone diagnostics providers.
- Adoption depends on providers recognizing operational benefits and payers covering test costs.
Valye Beyond the Headlines
- Materiality gate centers on Epic client adoption and resulting volume growth.
- Key milestones include Epic marketplace listing, pilot site activation, and usage metrics.
- Reimbursement clarity for the integrated tests is required for scalable commercial impact.
- No disclosed financial forecast or guidance updates linked to this collaboration.
- Execution risk relates to integration timelines and Epic client deployment schedules.
Tech Context
- Integration involves embedding test ordering and result reporting directly into Epic workflows.
- Requires coordination on software compatibility, data standards, and user interface design.
- Supports data interoperability between diagnostics and clinical EHR systems.
- May include automated alerts or decision support triggered by test results.
- Facilitates real-time clinical decision-making for prenatal and oncology care teams.
Business Trends
- Partnership moves BillionToOne from standalone product delivery toward integrated healthcare solutions.
- Improved workflow efficiency could drive higher test volumes and customer satisfaction.
- Integration with Epic might bolster credibility and open doors to larger healthcare systems.
- Demonstrating clinical utility and patient outcome improvements will be key to adoption.
- Requires ongoing collaboration to update and maintain integration as Epic evolves.
- Potentially reduces provider barriers to ordering complex molecular tests.
- Scalability depends on Epic’s rollout pace and healthcare provider IT adoption rates.
- No direct commentary on pricing or reimbursement changes linked to this collaboration.
Risks / what to watch
- Unclear Epic deployment timetable may delay adoption gains.
- Provider adoption is not guaranteed despite integration; clinical workflows vary widely.
- Reimbursement uncertainties for these tests remain a gating factor for volume growth.
- Epic’s platform updates could require ongoing integration work and investment.
- Competition from other molecular diagnostics also pursuing EHR integrations.
- Potential regulatory changes affecting test usage or data sharing practices.
- Measurement of clinical impact and provider satisfaction will affect scaling decisions.
- Dependence on Epic’s client base limits diversification of end users.
- Economic pressures on healthcare systems could constrain testing budgets.
News Context
- BillionToOne announced collaboration with Epic on January 15, 2026.
- Integration targets UNITY Complete® prenatal test and Northstar® oncology test.
- Ordering and results delivery will be enabled within Epic’s EHR platform.
- The integration intends to improve both patient and provider experience.
- No specific timeline or scale for deployment disclosed.
Sources
This article is general in nature and often relies heavily on company press releases and other third-party public sources, which may be promotional, incomplete, or occasionally inaccurate. It also incorporates AI-generated analysis, assumptions, scenarios, and broader public background context to help place the news in a wider industry narrative. As a result, it may contain errors or omissions. Always verify important details using primary sources (company filings, official releases, and direct statements). This is not financial advice and is not a recommendation to buy or sell any security.
Disclaimer: Research-only. Not investment advice.
Comments